• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

galatherapeutics

Gala Therapeutics wins FDA breakthrough nod for RheOx

September 16, 2019 By Sean Whooley

Gala Therapeutics said today that it won breakthrough device designation from the FDA for its RheOx bronchial rheoplasty device for patients with chronic bronchitis. Menlo Park, Calif.-based Gala’s RheOx system is designed for the minimally invasive delivery of non-thermal energy to airways, reducing mucus-producing cells associated with chronic bronchitis. Current treatments target bronchodilation and inflammation […]

Filed Under: Clinical Trials, Featured, Food & Drug Administration (FDA), Regulatory/Compliance, Respiratory Tagged With: FDA, galatherapeutics

Gala Therapeutics launches RheOx chronic bronchitis trial

November 5, 2018 By Fink Densford

Gala Therapeutics said today that it launched an early feasibility study of its RheOx system for treating chronic bronchitis, and that the first two patients in the trial have already been enrolled. Initial patient enrollment took place at the University of Pittsburgh Medical Center, with RheOx bronchial rheoplasty procedures performed by Dr. Frank Sciurba and Roy […]

Filed Under: Clinical Trials, Respiratory Tagged With: galatherapeutics

Gala Therapeutics wins FDA IDE nod for early feasibility trial of RheOx system

July 13, 2018 By Fink Densford

Gala Therapeutics said today it won FDA investigational device exemption approval to conduct an early feasibility study of its RheOx system designed to treat individuals with chronic bronchitis. The study will look to enroll up to 15 patients at five sites in the US, the Menlo Park, Calif.-based company said. “Patients with Chronic Bronchitis suffer […]

Filed Under: Food & Drug Administration (FDA), Regulatory/Compliance, Respiratory Tagged With: galatherapeutics

Primary Sidebar

DeviceTalks Weekly

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS